Buzzard Pharmaceuticals: Clinical Trials

3 trials sponsored by Buzzard Pharmaceuticals, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 2, Completed 1
Phase 12Completed 1, Recruiting 1

Follow Buzzard Pharmaceuticals: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Enhancing ICB Efficacy Through IL-1 Inhibition in TNBC
Group 1-Isunakinra - Triple-Negative Breast Cancer (TNBC)
Phase 1 / Phase 2RecruitingUniversity Health Network, Toronto602026-10-202026-10-29
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
isunakinra - Colorectal Cancer Metastatic
Phase 2RecruitingBuzzard Pharmaceuticals202025-01-302026-10-23
Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid Tumors
Isunakinra, PD-(L)1 Inhibitor - Solid Tumor, Adult
Phase 1 / Phase 2CompletedBuzzard Pharmaceuticals152020-09-012024-08-06

Conditions studied

Colorectal Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Triple Negative Breast Neoplasms (1)

Interventions

EBI-005 (2)

Countries

United States (2)  ·  Canada (1)

Top investigators

Maarten de Chateau, MD, PhD (1)